Notify me when Michael Catelani files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ANIX | Anixa Biosciences, Inc. | Common Stock | 7% | $10,662,205 | 2,468,103 | Michael Catelani | 05 Jan 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|